Quick Summary:
In the fast-evolving biomedical world, Human Embryonic Stem Cell (hESC) Research is a rapidly growing industry with profound implications for regenerative medicine. This expanding market is predicted to reach $1.3 billion by 2030, from $757.4 million in 2022. With the rise of regenerative treatments, the significance of such research holds immense potential for groundbreaking discoveries and advanced therapy options.
Within this valuable market research report, readers will gain a comprehensive understanding of the industry outlook and key players, while benchmarking their strategies against top competitors. With the assurance of complimentary updates for one year, the report guarantees up-to-date market insights to keep your business ahead of the curve. Additionally, it provides access to digital archives and a research platform, along with special interaction opportunities to facilitate growth. The opportunity to secure a strategically competitive edge in hESC Research awaits with this all-inclusive report.
Global Human Embryonic Stem Cell (hESC) Research Market to Reach $1.3 Billion by 2030
The global market for Human Embryonic Stem Cell (hESC) Research estimated at US$757.4 Million in the year 2022, is projected to reach a revised size of US$1.3 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2022-2030. Regenerative Medicine, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$892.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Stem Cell Biology Research segment is readjusted to a revised 7.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $221.6 Million, While China is Forecast to Grow at 6.1% CAGR
The Human Embryonic Stem Cell (hESC) Research market in the U.S. is estimated at US$221.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$219.3 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 5.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.Select Competitors (Total 24 Featured) -
- Astellas Institute of Regenerative Medicine
- Asterias Biotherapeutics, Inc.
- BD Biosciences
- Cell Cure Neurosciences Ltd.
- Cellular Dynamics International
- GE Healthcare
- PerkinElmer, Inc.
- Reliance Life Sciences Ltd.
- Research & Diagnostics Systems, Inc.
- STEMCELL Technologies, Inc.
- Stemina Biomarker Discovery, Inc.
- Takara Bio, Inc.
- TATAA Biocenter AB
- Thermo Fischer Scientific Inc.
- UK Stem Cell Bank
- ViaCyte, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Human Embryonic Stem Cell (hESC) Research?
What is the growth rate of the Global Market for Human Embryonic Stem Cell (hESC) Research?
What is the forecasted size of the Global Market for Human Embryonic Stem Cell (hESC) Research?
Who are the key companies in the Global Market for Human Embryonic Stem Cell (hESC) Research?
| Report Attribute | Details |
|---|---|
| No. of Pages | 184 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 757.4 Million |
| Forecasted Market Value ( USD | $ 1300 Million |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Astellas Institute of Regenerative Medicine
- Asterias Biotherapeutics, Inc.
- BD Biosciences
- Cell Cure Neurosciences Ltd.
- Cellular Dynamics International
- GE Healthcare
- PerkinElmer, Inc.
- Reliance Life Sciences Ltd.
- Research & Diagnostics Systems, Inc.
- STEMCELL Technologies, Inc.
- Stemina Biomarker Discovery, Inc.
- Takara Bio, Inc.
- TATAA Biocenter AB
- Thermo Fischer Scientific Inc.
- UK Stem Cell Bank
- ViaCyte, Inc.
